Aspirin as antiplatelet agent in diabetes. PROS-.
Davì
G
G
Center of Excellence on Aging, G. d'Annunzio University Foundation, Via Colle dell'Ara, Chieti, Italy. gdavi@unich.it
Santilli
F
F
D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D013927:Thrombosis / Q000517:prevention & control*
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin